Diabetes Institute

The UF Diabetes Institute’s mission is to see a world free of diabetes.

UF Health Diabetes Institute Statistics: #3 in N.I.H. funding for Type 1 Diabetes; #1 world's top recipient of J.D.R.F. research funding; 19,000 patient visit per year; 100 investigators in 9 colleges and 26 departments; $49,000,000 in current diabetes-related research awards.
  • Lead the Network for Pancreatic Organ donors with Diabetes program (nPOD), which collects and uses tissue samples from organ donors for research. This is but one of five programs collecting organ donor tissues, with a combined annual budget of over $6 million.

  • One of five institutions nationwide selected by the NIH to help create a groundbreaking 3D cellular map of the human body that may one day transform understanding of diseases; the $5.1 million, nearly four-year HuBMAP grant will allow UF Health researchers to map key parts of the lymphatic system, which helps fight infections and disease.

  • Leadership in international Type 1 diabetes research consortia focusing on Type 1 diabetes risk screening and innovative clinical studies (TrialNet); environmental determinants of Type 1 diabetes in children (The TEDDY study); and clinical trials studying oral insulin, pancreas volume and other therapies.

  • Creation of programs designed to identify barriers to leading-edge technologies that would lead to improved diabetes management, including those of migrant populations to the U.S.

  • Led by Dr. Kenneth Cusi, UF is a global leader in the studies of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, conditions often associated with Type 2 diabetes.